However, RSK phosphorylation is constantly suppressed by all ERK inhibitors tested, suggesting that RSK phosphorylation should be a reliable ERK activation marker regardless of cell types and inhibitors in NB. Here, RPS6KA1 is linked to neuroblastoma.